Northern Trust’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387M Sell
1,725,693
-59,691
-3% -$14.9M 0.05% 312
2025
Q4
$430M Buy
1,785,384
+87,502
+5% +$22.4M 0.05% 290
2025
Q3
$465M Sell
1,697,882
-17,379
-1% -$4.75M 0.06% 275
2025
Q2
$443M Sell
1,715,261
-29,280
-2% -$6.98M 0.06% 275
2025
Q1
$391M Buy
1,744,541
+41,951
+2% +$9.79M 0.06% 297
2024
Q4
$389M Buy
1,702,590
+290,664
+21% +$70M 0.06% 293
2024
Q3
$345M Sell
1,411,926
-53,331
-4% -$11.9M 0.06% 299
2024
Q2
$280M Buy
1,465,257
+43,131
+3% +$8.75M 0.05% 339
2024
Q1
$282M Sell
1,422,126
-29,825
-2% -$5.47M 0.05% 350
2023
Q4
$250M Sell
1,451,951
-39,318
-3% -$6.04M 0.05% 367
2023
Q3
$221M Sell
1,491,269
-124,456
-8% -$22.5M 0.04% 384
2023
Q2
$353M Sell
1,615,725
-132,785
-8% -$29.6M 0.07% 282
2023
Q1
$383M Sell
1,748,510
-116,364
-6% -$25.2M 0.08% 258
2022
Q4
$388M Sell
1,864,874
-12,894
-0.7% -$2.83M 0.08% 250
2022
Q3
$410M Sell
1,877,768
-149,181
-7% -$34M 0.09% 208
2022
Q2
$425M Sell
2,026,949
-145,912
-7% -$31.1M 0.09% 211
2022
Q1
$527M Sell
2,172,861
-69,214
-3% -$16.7M 0.09% 205
2021
Q4
$584M Sell
2,242,075
-16,066
-0.7% -$4.17M 0.1% 189
2021
Q3
$595M Buy
2,258,141
+96,984
+4% +$26.5M 0.11% 171
2021
Q2
$533M Sell
2,161,157
-71,095
-3% -$14.9M 0.09% 191
2021
Q1
$433M Sell
2,232,252
-43,728
-2% -$8.77M 0.08% 226
2020
Q4
$484M Buy
2,275,980
+25,927
+1% +$5.17M 0.09% 190
2020
Q3
$386M Buy
2,250,053
+130,919
+6% +$24.2M 0.08% 205
2020
Q2
$407M Buy
2,119,134
+65,764
+3% +$10.8M 0.1% 184
2020
Q1
$302M Buy
2,053,370
+8,605
+0.4% +$1.37M 0.09% 209
2019
Q4
$317M Buy
2,044,765
+35,037
+2% +$5.05M 0.07% 260
2019
Q3
$272M Buy
2,009,728
+17,701
+0.9% +$2.32M 0.07% 284
2019
Q2
$243M Buy
1,992,027
+37,217
+2% +$4.12M 0.06% 318
2019
Q1
$203M Buy
1,954,810
+276,097
+16% +$28.5M 0.05% 342
2018
Q4
$191M Buy
1,678,713
+59,166
+4% +$6.34M 0.05% 317
2018
Q3
$187M Sell
1,619,547
-15,407
-0.9% -$1.69M 0.05% 375
2018
Q2
$169M Sell
1,634,954
-4,766
-0.3% -$482K 0.04% 400
2018
Q1
$161M Sell
1,639,720
-37,431
-2% -$3.54M 0.04% 410
2017
Q4
$142M Buy
1,677,151
+3,329
+0.2% +$275K 0.04% 463
2017
Q3
$129M Buy
1,673,822
+199,897
+14% +$15.3M 0.03% 470
2017
Q2
$115M Buy
1,473,925
+118,428
+9% +$8.47M 0.03% 482
2017
Q1
$97.6M Buy
1,355,497
+32,093
+2% +$2.22M 0.03% 533
2016
Q4
$82.1M Buy
1,323,404
+17,573
+1% +$1.08M 0.03% 581
2016
Q3
$84.6M Sell
1,305,831
-24,938
-2% -$1.66M 0.03% 563
2016
Q2
$84.1M Buy
1,330,769
+66,392
+5% +$3.91M 0.03% 550
2016
Q1
$72.6M Buy
1,264,377
+39,844
+3% +$2.26M 0.02% 593
2015
Q4
$65.7M Sell
1,224,533
-77,238
-6% -$4.35M 0.02% 637
2015
Q3
$66.3M Sell
1,301,771
-20,392
-2% -$1.1M 0.02% 633
2015
Q2
$74.5M Sell
1,322,163
-20,697
-2% -$1.31M 0.02% 624
2015
Q1
$96.4M Sell
1,342,860
-2,439
-0.2% -$158K 0.03% 525
2014
Q4
$75.4M Sell
1,345,299
-47,957
-3% -$2.5M 0.02% 609
2014
Q3
$68.6M Sell
1,393,256
-28,535
-2% -$1.45M 0.02% 615
2014
Q2
$72M Sell
1,421,791
-16,176
-1% -$802K 0.02% 604
2014
Q1
$64.3M Sell
1,437,967
-61,243
-4% -$2.75M 0.02% 669
2013
Q4
$70.6M Buy
1,499,210
+9,964
+0.7% +$504K 0.02% 583
2013
Q3
$78.7M Sell
1,489,246
-32,632
-2% -$1.58M 0.03% 506
2013
Q2
$68.7M Buy
+1,521,878
New +$72.2M 0.02% 525

Other funds holding RMD

Northern Trust's RMD Position: Q1 2026 in Review

Northern Trust reduced its ResMed (RMD) stake by 3.3% in Q1 2026, selling an estimated $14.9M and leaving 1,725,693 shares worth $387M. The position accounts for 0.05% of the portfolio, ranked #312.

Northern Trust first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $595M in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Northern Trust held 1,725,693 shares of ResMed worth $387M as of Q1 2026.
  • Northern Trust sold 59,691 ResMed shares in Q1 2026, an estimated $14.9M.
  • ResMed made up 0.05% of Northern Trust's portfolio in Q1 2026, its #312 holding.
  • Northern Trust first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's ResMed position peaked at $595M in Q3 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.